Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 1Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 4NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 38Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Colorectal Neoplasms 14Prostatic Neoplasms 13Head and Neck Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Sarcoma 10Neoplasms 9Ovarian Neoplasms 8Uterine Cervical Neoplasms 7Rectal Neoplasms 7Lymphoma 7Lung Neoplasms 7Leukemia 7Colonic Neoplasms 7Urinary Bladder Neoplasms 6Stomach Neoplasms 6Pain 6Neoplasm Metastasis 6Fallopian Tube Neoplasms 6Hodgkin Disease 5Burkitt Lymphoma 5Breast Carcinoma In Situ 5Brain Neoplasms 5Testicular Neoplasms 4Teratoma 4Squamous Cell Carcinoma of Head and Neck 4Recurrence 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × NETWORK × Diffuse Intrinsic Pontine Glioma × Clear all
NCT03033992 2026-04-06

Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG

Children's Oncology Group

Phase NA Active not recruiting
80 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡